Ordering Recommendation

Molecular testing is preferred for patients presenting with meningitis/encephalitis. Refer to Meningitis/Encephalitis Panel by PCR (2013305).

New York DOH Approval Status

This test is not New York state approved. There are no New York state-approved laboratories available and NYDOH is not accepting Non-permitted Laboratory Requests (NPL). Do not submit sample to ARUP.

Specimen Required

Patient Preparation
Collect

CSF.

Specimen Preparation

Transfer 5.0mL CSF to an ARUP standard transport tube. (Min: 2.5mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Serum or plasma. Contaminated, heat-inactivated, or hemolyzed specimens.

Remarks
Stability

Ambient: 8 hours; Refrigerated: 2 weeks; Frozen: 1 month

Methodology

Semi-Quantitative Enzyme-Linked Immunosorbent Assay (ELISA) / Semi-Quantitative Chemiluminescent Immunoassay (CLIA) / Semi-Quantitative Indirect Fluorescent Antibody (IFA)

Performed

Sun-Sat

Reported

4-6 days

Reference Interval

Test Number
Components
Reference Interval
  West Nile Virus Antibody IgG CSF 1.29 IV or less
  West Nile Virus Antibody IgM CSF 0.89 IV or less
  HSV 1/2 Antibody Screen IgG, CSF 0.89 IV or less
  Measles, Rubeola, Antibody IgG CSF 16.4 AU/mL or less
  Measles, Rubeola, Antibody IgM CSF Less than 1:2
  Mumps Virus Antibody IgG CSF 10.9 AU/mL or less
  Mumps Virus Antibody IgM CSF 0.79 IV or less
  VZV Antibody IgM CSF 0.90 ISR or less
  VZV Antibody IgG CSF
<=0.99 S/CO Negative - No significant level of IgG antibody to varicella-zoster virus detected.
>=1.00 S/CO Positive - IgG antibody to varicella-zoster virus detected, which may indicate a current or past varicella-zoster infection.

Interpretive Data




Component
Interpretation
Measles (Rubeola) Antibody, IgG, CSF 13.4 AU/mL or less:  Negative. No significant level of IgG antibody to measles (rubeola) virus detected.
13.5-16.4 AU/mL:  Equivocal. Repeat testing in 10-14 days may be helpful.
16.5 AU/mL or greater:  Positive. IgG antibody to measles (rubeola) detected, which may indicate a current or past measles (rubeola) infection.
Measles (Rubeola) Antibody, IgM, CSF Less than 1:2: Negative. No evidence of recent infection. False-negative results are possible if the specimen was collected too soon after exposure.
1:2 or greater: Positive. Indicative of recent primary measles infection.
Mumps Virus Antibody IgG, CSF 8.9 AU/mL or less:  Negative. No significant level of detectable IgG mumps virus antibody.
9.0-10.9 AU/mL:  Equivocal. Repeat testing in 10-14 days may be helpful.
11.0 AU/mL or greater:  Positive. IgG antibody to mumps virus detected, which may indicate a current or past mumps virus infection.
Mumps Virus Antibody IgM, CSF 0.79 IV or less:  Negative. No significant level of detectable IgM antibody to mumps virus.
0.80-1.20 IV:  Equivocal. Borderline levels of IgM antibody to mumps virus. Repeat testing in 10-14 days may be helpful.
1.21 IV or greater:  Positive. Presence of IgM antibody to mumps virus detected, which may indicate a current or recent infection. However, low levels of IgM antibody may occasionally persist for more than 12 months post infection or immunization.
Varicella-Zoster Virus Antibody, IgG, CSF Less than or equal to 0.99 S/CO: Negative: No significant level of IgG antibody to varicella-zoster virus detected.
Greater than or equal to 1.00 S/CO: Positive: IgG antibody to varicella-zoster virus detected, which may indicate a current or past varicella-zoster infection.
Varicella-Zoster Virus Antibody, IgM by ELISA (CSF) 0.90 ISR or less:  Negative. No significant level of IgM antibody to varicella-zoster virus detected.
0.91-1.09 ISR:  Equivocal. Repeat testing in 10-14 days may be helpful.
1.10 ISR or greater:  Positive. Significant level of IgM antibody to varicella-zoster virus detected, which may indicate current or recent infection. However, low levels of IgM antibodies may occasionally persist for more than 12 months post infection.
Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG, CSF 0.89 IV or less:  Negative. No significant level of detectable HSV IgG antibody.
0.90-1.09 IV:  Equivocal. Questionable presence of IgG antibodies. Repeat testing in 10-14 days may be helpful.
1.10 IV or greater:  Positive. IgG antibody to HSV detected which may indicate a current or past HSV infection.
West Nile Virus Antibody, IgG by ELISA, CSF 1.29 IV or less:  Negative. No significant level of West Nile virus IgG antibody detected.
1.30-1.49 IV:  Equivocal. Questionable presence of West Nile virus IgG antibody detected. Repeat testing in 10-14 days may be helpful.
1.50 IV or greater:  Positive. Presence of IgG antibody to West Nile virus detected, suggestive of current or past infection.
West Nile Virus Antibody, IgM by ELISA, CSF 0.89 IV or less:  Negative. No significant level of West Nile virus IgM antibody detected.
0.90-1.10 IV:  Equivocal. Questionable presence of West Nile virus IgM antibody detected. Repeat testing in 10-14 days may be helpful.
1.11 IV or greater:  Positive. Presence of IgM antibody to West Nile virus detected, suggestive of current or recent infection.

Compliance Category

Laboratory Developed Test (LDT)

Note

  If HSV 1 and/or 2 IgG, CSF is 1.10 IV or greater, then HSV 1 G-specific IgG, CSF and HSV 2 G-specific IgG, CSF will be added. Additional charges apply.

Hotline History

N/A

CPT Codes

86765 x2; 86735 x2; 86787 x2; 86789; 86788; 86694; if reflexed, add 86695; 86696

Components

Component Test Code* Component Chart Name LOINC
0050238 West Nile Virus Antibody IgG CSF 39572-3
0050239 West Nile Virus Antibody IgM CSF 39573-1
0050394 HSV 1/2 Antibody Screen IgG, CSF 13249-8
0054440 Measles, Rubeola, Antibody IgG CSF 9566-1
0054441 Measles, Rubeola, Antibody IgM CSF 21502-0
0054442 Mumps Virus Antibody IgG CSF 13266-2
0054443 Mumps Virus Antibody IgM CSF 13267-0
0054444 VZV Antibody IgG CSF 58755-0
0054445 VZV Antibody IgM CSF 31695-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

Encephalitis Panel With Reflex to Herpes Simplex Virus Types 1 and 2 Glycoprotein G-Specific Antibodies, IgG, CSF